Alembic Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 16,305.7 million compared to INR 15,090.2 million a year ago. Revenue was INR 16,334.6 million compared to INR 15,094.6 million a year ago. Net income was INR 1,804.5 million compared to INR 1,219.2 million a year ago.
For the nine months, sales was INR 47,116.5 million compared to INR 42,461.7 million a year ago. Revenue was INR 47,363.6 million compared to INR 42,480.3 million a year ago. Net income was INR 4,376.1 million compared to INR 1,893.9 million a year ago.